支气管肺泡灌洗液细胞形态学检验中国专家共识(2020)

2020-12-30 中国检验科相关专家小组(统称) 现代检验医学杂志.2020.35(6):4-8.

支气管肺泡灌洗液细胞学检测是临床常用的检验项目之一,其对肺部疾病的诊断、鉴别诊断、指导临床治疗具有重要意义。该文通过介绍支气管肺泡灌洗液细胞学检验目的、标本采集、检验程序、报告模式、临床意义等内容,使

中文标题:

支气管肺泡灌洗液细胞形态学检验中国专家共识(2020)

发布日期:

2020-12-30

简要介绍:

支气管肺泡灌洗液细胞学检测是临床常用的检验项目之一,其对肺部疾病的诊断、鉴别诊断、指导临床治疗具有重要意义。该文通过介绍支气管肺泡灌洗液细胞学检验目的、标本采集、检验程序、报告模式、临床意义等内容,使其操作规范化、标准化,更好地发挥临床检验价值。

相关资料下载:
[AttachmentFileName(sort=1, fileName=支气管肺泡灌洗液细胞形态学检验中国专家共识_2020_周道银.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ce2931c0020a9627, title=支气管肺泡灌洗液细胞形态学检验中国专家共识(2020), enTitle=, guiderFrom=现代检验医学杂志.2020.35(6):4-8., authorId=0, author=, summary=支气管肺泡灌洗液细胞学检测是临床常用的检验项目之一,其对肺部疾病的诊断、鉴别诊断、指导临床治疗具有重要意义。该文通过介绍支气管肺泡灌洗液细胞学检验目的、标本采集、检验程序、报告模式、临床意义等内容,使, cover=https://img.medsci.cn/202128/1612793654689_2020535.jpg, journalId=0, articlesId=null, associationId=875, associationName=中国检验科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Dec 30 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>支气管肺泡灌洗液细胞学检测是临床常用的检验项目之一,其对肺部疾病的诊断、鉴别诊断、指导临床治疗具有重要意义。该文通过介绍支气管肺泡灌洗液细胞学检验目的、标本采集、检验程序、报告模式、临床意义等内容,使其操作规范化、标准化,更好地发挥临床检验价值。</p> </div> </div> </div>, tagList=[TagDto(tagId=45940, tagName=支气管肺泡灌洗液)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=69, categoryName=检验与病理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=45940, guiderKeyword=支气管肺泡灌洗液, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7390, appHits=232, showAppHits=0, pcHits=957, showPcHits=7157, likes=1, shares=16, comments=7, approvalStatus=1, publishedTime=Mon Feb 08 23:57:33 CST 2021, publishedTimeString=2020-12-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Feb 08 22:14:20 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:55:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=支气管肺泡灌洗液细胞形态学检验中国专家共识_2020_周道银.pdf)])
支气管肺泡灌洗液细胞形态学检验中国专家共识_2020_周道银.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200910, encodeId=465e12009102c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd1d5173668, createdName=146e0a25m74暂无昵称, createdTime=Wed Mar 09 15:38:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186585, encodeId=998a1186585ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87e35104516, createdName=y晶晶, createdTime=Thu Jan 20 20:55:20 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067131, encodeId=096d106e13121, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:04:01 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960967, encodeId=2f0996096e25, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:26:06 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956814, encodeId=5fd39568142b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceec5290383, createdName=14860c44m87(暂无昵称), createdTime=Wed Apr 14 09:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2022-03-09 146e0a25m74暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200910, encodeId=465e12009102c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd1d5173668, createdName=146e0a25m74暂无昵称, createdTime=Wed Mar 09 15:38:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186585, encodeId=998a1186585ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87e35104516, createdName=y晶晶, createdTime=Thu Jan 20 20:55:20 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067131, encodeId=096d106e13121, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:04:01 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960967, encodeId=2f0996096e25, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:26:06 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956814, encodeId=5fd39568142b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceec5290383, createdName=14860c44m87(暂无昵称), createdTime=Wed Apr 14 09:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2022-01-20 y晶晶

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200910, encodeId=465e12009102c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd1d5173668, createdName=146e0a25m74暂无昵称, createdTime=Wed Mar 09 15:38:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186585, encodeId=998a1186585ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87e35104516, createdName=y晶晶, createdTime=Thu Jan 20 20:55:20 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067131, encodeId=096d106e13121, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:04:01 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960967, encodeId=2f0996096e25, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:26:06 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956814, encodeId=5fd39568142b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceec5290383, createdName=14860c44m87(暂无昵称), createdTime=Wed Apr 14 09:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-11-05 未来将来

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1200910, encodeId=465e12009102c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd1d5173668, createdName=146e0a25m74暂无昵称, createdTime=Wed Mar 09 15:38:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186585, encodeId=998a1186585ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87e35104516, createdName=y晶晶, createdTime=Thu Jan 20 20:55:20 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067131, encodeId=096d106e13121, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:04:01 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960967, encodeId=2f0996096e25, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:26:06 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956814, encodeId=5fd39568142b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceec5290383, createdName=14860c44m87(暂无昵称), createdTime=Wed Apr 14 09:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-04-27 gujun830412

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1200910, encodeId=465e12009102c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd1d5173668, createdName=146e0a25m74暂无昵称, createdTime=Wed Mar 09 15:38:02 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186585, encodeId=998a1186585ce, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87e35104516, createdName=y晶晶, createdTime=Thu Jan 20 20:55:20 CST 2022, time=2022-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067131, encodeId=096d106e13121, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Fri Nov 05 06:04:01 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=960967, encodeId=2f0996096e25, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/10/f6f1f6ef2f0f4f5eb8d6b9f97243bb3f.jpg, createdBy=c5102133863, createdName=gujun830412, createdTime=Tue Apr 27 15:26:06 CST 2021, time=2021-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956814, encodeId=5fd39568142b, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ceec5290383, createdName=14860c44m87(暂无昵称), createdTime=Wed Apr 14 09:49:17 CST 2021, time=2021-04-14, status=1, ipAttribution=)]